ATE513901T1 - Neurale vorläuferzellen - Google Patents

Neurale vorläuferzellen

Info

Publication number: ATE513901T1
Authority: AT; Austria
Prior art keywords: neural progenitor; progenitor cells; cells; precursor cells; mass
Prior art date: 2001-10-25

Application number

AT08075134T

Other languages

English (en)

Inventor

John S Yu

Peter Kabos

Moneeb Ehtesham

Original Assignee

Cedars Sinai Medical Center

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-25

Filing date

2002-10-18

Publication date

2011-07-15

2002-10-18 Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center

2011-07-15 Application granted granted Critical

2011-07-15 Publication of ATE513901T1 publication Critical patent/ATE513901T1/de

Links

230000001537 neural effect Effects 0.000 title 1
239000002243 precursor Substances 0.000 title 1
210000005155 neural progenitor cell Anatomy 0.000 abstract 3
102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract 2
210000004027 cell Anatomy 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
230000002981 neuropathic effect Effects 0.000 abstract 1
210000000130 stem cell Anatomy 0.000 abstract 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Developmental Biology & Embryology (AREA)
Heart & Thoracic Surgery (AREA)
Cell Biology (AREA)
Cardiology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT08075134T 2001-10-25 2002-10-18 Neurale vorläuferzellen ATE513901T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33495701P	2001-10-25	2001-10-25
US10/253,759 US7129034B2 (en)	2001-10-25	2002-09-24	Differentiation of whole bone marrow

Publications (1)

Publication Number	Publication Date
ATE513901T1 true ATE513901T1 (de)	2011-07-15

Family

ID=26943536

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT08075134T ATE513901T1 (de)	2001-10-25	2002-10-18	Neurale vorläuferzellen
AT02784173T ATE387491T1 (de)	2001-10-25	2002-10-18	Differenzierung vom gesamten knochenmark

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT02784173T ATE387491T1 (de)	2001-10-25	2002-10-18	Differenzierung vom gesamten knochenmark

Country Status (6)

Country	Link
US (5)	US7129034B2 (de)
EP (2)	EP1956079B1 (de)
JP (2)	JP2005531279A (de)
AT (2)	ATE513901T1 (de)
DE (1)	DE60225310T2 (de)
WO (1)	WO2003035855A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7129034B2 (en) *	2001-10-25	2006-10-31	Cedars-Sinai Medical Center	Differentiation of whole bone marrow
JP4648628B2 (ja)	2002-03-13	2011-03-09	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	ヒストンデアセチラーゼの新規な阻害剤としてのカルボニルアミノ誘導体
CA2476583C (en)	2002-03-13	2011-07-05	Kristof Van Emelen	Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US8518390B2 (en)	2003-06-27	2013-08-27	Advanced Technologies And Regenerative Medicine, Llc	Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US8491883B2 (en) *	2003-06-27	2013-07-23	Advanced Technologies And Regenerative Medicine, Llc	Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US20100158880A1 (en) *	2008-12-19	2010-06-24	Ethicon, Incorporated	Regeneration and repair of neural tissue following injury
ES2569780T3 (es) *	2003-06-27	2016-05-12	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US8426200B2 (en) *	2003-07-02	2013-04-23	Regents Of The University Of Minnesota	Neuronal differentiation of stem cells
EP1506997A1 (de) *	2003-08-14	2005-02-16	NeuroProgen GmbH Leipzig	Verfahren zur Erzeugung von neuronalen Stammzellen
US20070269412A1 (en)	2003-12-02	2007-11-22	Celavie Biosciences, Llc	Pluripotent cells
CN1993460A (zh) *	2004-07-12	2007-07-04	索林集团意大利有限公司	用于培养人细胞的装置和方法
HRP20120327T1 (hr)	2004-07-28	2012-05-31	Janssen Pharmaceutica Nv	Supstituirani indolil alkil amino derivati kao novi inhibitori histonske deacetilaze
WO2006101548A2 (en) *	2004-12-21	2006-09-28	Ethicon, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060153815A1 (en) *	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
WO2006083394A2 (en) *	2004-12-21	2006-08-10	Ethicon, Inc.	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
CA2589063C (en)	2004-12-23	2016-08-09	DePuy Synthes Products, Inc.	Treatment of parkinson's disease and related disorders using postpartum derived cells
ES2621847T3 (es)	2004-12-23	2017-07-05	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
JP4905719B2 (ja) *	2005-02-10	2012-03-28	公益財団法人新産業創造研究機構	神経幹細胞の調製法
US20060183712A1 (en) *	2005-02-17	2006-08-17	The Texas A&M University System	Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
EP1855700B1 (de)	2005-03-07	2013-10-30	SanBio, Inc.	Verwendung von neuronalen vorläuferzellen zur behandlung von läsionen des zentralnervensystems
CA2623360C (en)	2005-10-27	2014-04-22	Janssen Pharmaceutica N.V.	Squaric acid derivatives as inhibitors of histone deacetylase
US9175261B2 (en) *	2005-12-16	2015-11-03	DePuy Synthes Products, Inc.	Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
ES2391034T3 (es) *	2005-12-19	2012-11-20	Ethicon, Inc.	Expansión in vitro de células derivadas postparto en frascos rotatorios
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
CN101437576A (zh) *	2005-12-28	2009-05-20	伊西康公司	使用产后衍生细胞治疗外周血管疾病
EP1979326B1 (de)	2006-01-19	2012-10-03	Janssen Pharmaceutica N.V.	Pyridin- und pyrimidinderivate als inhibitoren von histondeacetylase
EP2607477B1 (de)	2007-05-03	2020-09-23	The Brigham and Women's Hospital, Inc.	Multipotente stammzellen und ihre verwendung
US8574567B2 (en)	2007-05-03	2013-11-05	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US20090081276A1 (en) *	2007-08-13	2009-03-26	Eben Alsberg	Bioresorbable implant composition
EP2203186B1 (de) *	2007-10-05	2014-09-24	DePuy Synthes Products, LLC	Reparatur und regeneration von nierengewebe mit zellen aus menschlicher nabelschnur
ES2787513T3 (es)	2007-12-03	2020-10-16	Sanbio Inc	Métodos y composiciones para modular la diferenciación de células pluripotenciales
US8236538B2 (en) *	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
US9198597B2 (en) *	2008-05-22	2015-12-01	Christopher Duma	Leading-edge cancer treatment
WO2010071862A1 (en) *	2008-12-19	2010-06-24	Ethicon, Incorporated	Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
US10557116B2 (en)	2008-12-19	2020-02-11	DePuy Synthes Products, Inc.	Treatment of lung and pulmonary diseases and disorders
US10179900B2 (en) *	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
US20100209399A1 (en) *	2009-02-13	2010-08-19	Celavie Biosciences, Llc	Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects
PL2411504T3 (pl)	2009-03-26	2017-10-31	Depuy Synthes Products Inc	Komórki ludzkiej tkanki pępowinowej jako terapia choroby Alzheimera
US9109206B2 (en)	2009-10-16	2015-08-18	Rutgers, The State University Of New Jersey	Method for treating chronic nerve tissue injury using a cell therapy strategy
KR101981450B1 (ko)	2011-12-23	2019-08-28	디퍼이 신테스 프로덕츠, 인코포레이티드	인간 제대 조직-유래된 세포의 검출
JP2016520291A (ja)	2013-03-14	2016-07-14	ザリージェンツオブザユニバーシティオブカリフォルニア	ｉｎｖｉｔｒｏでの内側神経節隆起前駆細胞の作製
US11464804B1 (en)	2017-11-15	2022-10-11	Enrico Stazzone	Intrathecal multifactorial infusion of heterogeneous autologous cell therapy

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4965204A (en)	1984-02-06	1990-10-23	The Johns Hopkins University	Human stem cells and monoclonal antibodies
US5130144B1 (en)	1984-02-06	1995-08-15	Univ Johns Hopkins	Human stem cells and monoclonal antibodies
US4714680B1 (en)	1984-02-06	1995-06-27	Univ Johns Hopkins	Human stem cells
WO1990001541A1 (en)	1988-08-04	1990-02-22	Amrad Corporation Limited	In vitro propagation of embryonic stem cells
US5399493A (en)	1989-06-15	1995-03-21	The Regents Of The University Of Michigan	Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5437994A (en)	1989-06-15	1995-08-01	Regents Of The University Of Michigan	Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5061620A (en)	1990-03-30	1991-10-29	Systemix, Inc.	Human hematopoietic stem cell
US5612211A (en) *	1990-06-08	1997-03-18	New York University	Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5556783A (en)	1991-03-27	1996-09-17	Trustees Of Univ. Of Penna	Methods of culturing and modulating the growth of hair follicular stem cells
US5367057A (en)	1991-04-02	1994-11-22	The Trustees Of Princeton University	Tyrosine kinase receptor flk-2 and fragments thereof
US5851832A (en)	1991-07-08	1998-12-22	Neurospheres, Ltd.	In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5429938A (en)	1992-03-02	1995-07-04	University Of Michigan	Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5436151A (en)	1992-04-03	1995-07-25	Regents Of The University Of Minnesota	Method for culturing human hematopoietic stem cells in vitro
US5589376A (en)	1992-07-27	1996-12-31	California Institute Of Technology	Mammalian neural crest stem cells
US5928947A (en)	1992-07-27	1999-07-27	California Institute Of Technology	Mammalian multipotent neural stem cells
US5849553A (en)	1992-07-27	1998-12-15	California Institute Of Technology	Mammalian multipotent neural stem cells
US5654183A (en)	1992-07-27	1997-08-05	California Institute Of Technology	Genetically engineered mammalian neural crest stem cells
JPH08500245A (ja)	1992-07-27	1996-01-16	カリフォルニアインスティテュートオブテクノロジー	哺乳動物の多能性神経幹細胞
US5766948A (en) *	1993-01-06	1998-06-16	The Regents Of The University Of California	Method for production of neuroblasts
GB9308271D0 (en)	1993-04-21	1993-06-02	Univ Edinburgh	Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5772994A (en)	1993-05-28	1998-06-30	The University Of Pittsburgh	Hematopoietic facilitatory cells and their uses
WO1995005843A1 (en)	1993-08-25	1995-03-02	Systemix, Inc.	Method for producing a highly enriched population of hematopoietic stem cells
IL107483A0 (en)	1993-11-03	1994-02-27	Yeda Res & Dev	Bone marrow transplantation
US5599705A (en)	1993-11-16	1997-02-04	Cameron; Robert B.	In vitro method for producing differentiated universally compatible mature human blood cells
US5449620A (en)	1994-01-25	1995-09-12	Thomas Jefferson University	Apparatus and method for culturing embryonic stem cells
FI971168L (fi)	1994-09-23	1997-03-20	Neurospheres Holdings Ltd	Keskushermoston toiminnan ja häiriön in vitro -mallit
US6204053B1 (en)	1994-11-08	2001-03-20	Diacrin, Inc.	Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
FI971956L (fi)	1994-11-14	1997-07-04	Neurospheres Holdings Ltd	Hermosolujen lisääntymisen säännöstely
US5665557A (en)	1994-11-14	1997-09-09	Systemix, Inc.	Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
US5677136A (en)	1994-11-14	1997-10-14	Systemix, Inc.	Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5728581A (en)	1995-06-07	1998-03-17	Systemix, Inc.	Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
US5753506A (en)	1996-05-23	1998-05-19	Cns Stem Cell Technology, Inc.	Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
AU5436998A (en)	1996-11-15	1998-06-03	Osiris Therapeutics, Inc.	MSC-megakaryocyte precursor composition and method of isolating MSCs asso ciated with isolated megakaryocytes by isolating megakaryocytes
US5968829A (en)	1997-09-05	1999-10-19	Cytotherapeutics, Inc.	Human CNS neural stem cells
EP1096941B1 (de) *	1998-05-07	2005-08-10	University Of South Florida	Knochenmarkszellen als quelle von neuronen zur wiederherstellung von gehirn und knochenmark
US7186409B2 (en) *	1998-08-14	2007-03-06	The Children's Medical Center Corporation	Neural stem cells and use thereof for brain tumor therapy
US20020115213A1 (en)	1998-08-14	2002-08-22	Northeastern Ohio Universities Of Medicine	Engraftable neural progenitor & stem cells for brain tumor therapy
US5958767A (en) *	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
DK1173548T3 (da)	1999-05-03	2007-10-08	Neuro Therapeutics Ab	Materialer og fremgangsmåder til frembringelse af dopaminerge neuroner
EP1263930A4 (de)	2000-03-09	2004-07-21	Saneron Ccel Therapeutics Inc	Menschliches nabelschnurblut als quelle für neurales gewebe zur heilung von gehirn und rückenmark
JP4800544B2 (ja)	2000-03-15	2011-10-26	チルドレンズメディカルセンターコーポレーション	腫瘍治療用の全身性遺伝子送達運搬体
EP1287116A2 (de) *	2000-05-17	2003-03-05	Geron Corporation	Neural vorläuferzellen
US20040092013A1 (en) *	2001-08-14	2004-05-13	Snyder Evan Y.	Method of treating alzheimer's disease with cell therapy
US9969980B2 (en) *	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US7129034B2 (en)	2001-10-25	2006-10-31	Cedars-Sinai Medical Center	Differentiation of whole bone marrow
US6842541B2 (en) *	2001-10-31	2005-01-11	Xerox Corporation	Adaptive color super resolution thresholding
AU2002350352A1 (en) *	2001-12-21	2003-07-15	Mount Sinai Hospital	Cellular compositions and methods of making and using them
US20070244046A1 (en) *	2006-03-29	2007-10-18	Margarita Gutova	Identification and characterization of cancer stem cells and methods of use

2002
- 2002-09-24 US US10/253,759 patent/US7129034B2/en not_active Expired - Lifetime
- 2002-10-18 WO PCT/US2002/033447 patent/WO2003035855A1/en not_active Ceased
- 2002-10-18 EP EP08075134A patent/EP1956079B1/de not_active Expired - Lifetime
- 2002-10-18 AT AT08075134T patent/ATE513901T1/de not_active IP Right Cessation
- 2002-10-18 DE DE60225310T patent/DE60225310T2/de not_active Expired - Lifetime
- 2002-10-18 EP EP02784173A patent/EP1438393B1/de not_active Expired - Lifetime
- 2002-10-18 JP JP2003538356A patent/JP2005531279A/ja active Pending
- 2002-10-18 AT AT02784173T patent/ATE387491T1/de not_active IP Right Cessation
2005
- 2005-09-23 US US11/234,520 patent/US20060029580A1/en not_active Abandoned
2006
- 2006-02-28 US US11/364,394 patent/US7504100B2/en not_active Expired - Lifetime
- 2006-02-28 US US11/364,454 patent/US20060148083A1/en not_active Abandoned
- 2006-05-15 US US11/433,996 patent/US8071366B2/en not_active Expired - Fee Related
2007
- 2007-12-27 JP JP2007338253A patent/JP2008099709A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
US20060148082A1 (en)	2006-07-06
US20060029580A1 (en)	2006-02-09
DE60225310D1 (de)	2008-04-10
US20030082160A1 (en)	2003-05-01
EP1956079B1 (de)	2011-06-22
EP1438393B1 (de)	2008-02-27
US20060205074A1 (en)	2006-09-14
EP1438393A1 (de)	2004-07-21
US8071366B2 (en)	2011-12-06
ATE387491T1 (de)	2008-03-15
US7129034B2 (en)	2006-10-31
JP2008099709A (ja)	2008-05-01
US20060148083A1 (en)	2006-07-06
EP1956079A1 (de)	2008-08-13
JP2005531279A (ja)	2005-10-20
DE60225310T2 (de)	2009-03-12
WO2003035855A1 (en)	2003-05-01
US7504100B2 (en)	2009-03-17

Legal Events

Date	Code	Title	Description
2011-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE387491T1 (de)	2008-03-15	Differenzierung vom gesamten knochenmark
ATE313634T1 (de)	2006-01-15	Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
DK1121064T3 (da)	2005-01-10	Fremgangsmåde og indretning til præparering af et tandomplantat ved nedsænkning i en kultur af mesenkymatöse celler
ATE534728T1 (de)	2011-12-15	Nestinexprimierende haarfollikelstammzellen
IL192762A0 (en)	2009-02-11	Method for identifying cell differentiation factors
DE60017875D1 (de)	2005-03-10	Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen
DE69933579D1 (de)	2006-11-23	Serum-freies medium für chondrozyt-ähnliche zellen
WO2002078449A3 (en)	2002-11-21	Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
PT1218509E (pt)	2009-06-16	Polipéptidos do tipo factor de crescimento de fibroblastos
GB0222846D0 (en)	2002-11-06	Cell culture
DE69837491D1 (de)	2007-05-16	Menschliche mesenchymale stammzellen aus peripherem blut
ATE526047T1 (de)	2011-10-15	Verbesserung der funktion von organen
KR100201663B1 (en)	1999-06-15	Methods, compositions and devices for growing cells
NO972171L (no)	1997-07-07	Regulering av neural stamcelleproliferasjon
CA2444724A1 (en)	2002-10-31	Method for differentiating mesenchymal stem cells into neural cells
BR0214029A (pt)	2005-04-19	Métodos e composições para o uso de células estromais para suportar células tronco embriÈnicas e adultas
EP1406643A4 (de)	2006-07-19	Physiologische gewebereparatur und funktionale organregeneration durch kultivierung von regenerativen stammzellen in vivo und in situ
DK1242578T3 (da)	2004-07-26	Celledyrkningsmedium indeholdende vækstfaktorer og L-glutamin
DK0783693T3 (da)	2002-01-14	In vitro-modeller for CNS-funktion og -dysfunktion
EP1019491A4 (de)	2001-06-06	Herstellung embryonischer vogel keimzellinien durch verlängerte kultivierung von pgcs, verwendung desselben zur klonierung und chimerisierung
AR034815A1 (es)	2004-03-17	Produccion de celulas gliales radiales
JP2005519591A5 (de)	2005-12-22
WO2003089581A3 (en)	2004-02-26	A method to increase the rate of cell growth
WO2002098361A3 (en)	2003-03-20	T cell induced tissue repair and regeneration
DE60326003D1 (de)	2009-03-12	Ter verwendung des hepatozytenwachstumsfaktors